Quick Answer
AtriCure, Inc. reported Operating Income of -$9.45 million for fiscal year 2025.
AtriCure, Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$9.45M | +76.4% |
| 2024 | -$40.01M | -50.0% |
| 2023 | -$26.68M | +37.5% |
| 2022 | -$42.67M | -177.3% |
| 2021 | $55.20M | +224.8% |
| 2020 | -$44.23M | -33.5% |
| 2019 | -$33.12M | -93.4% |
| 2018 | -$17.13M | +31.4% |
| 2017 | -$24.98M | +19.8% |
| 2016 | -$31.14M | -16.5% |
| 2015 | -$26.72M | -63.3% |
| 2014 | -$16.36M | -50.2% |
| 2013 | -$10.89M | -51.3% |
| 2012 | -$7.20M | -52.1% |
| 2011 | -$4.73M | -48.2% |
| 2010 | -$3.19M | +79.4% |
| 2009 | -$15.51M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $208.0K | +102.8% | +103.4% |
| June 30, 2025 | -$6.19M | +13.6% | -4.0% |
| March 31, 2025 | -$5.95M | +45.5% | +19.6% |
| September 30, 2024 | -$7.41M | +8.5% | -3.3% |
| June 30, 2024 | -$7.17M | -73.0% | +34.3% |
| March 31, 2024 | -$10.92M | -88.8% | -35.0% |
| September 30, 2023 | -$8.09M | +24.6% | -95.2% |
| June 30, 2023 | -$4.14M | +69.7% | +28.3% |
- AtriCure, Inc. showed an increase of +76.4% in Operating Income compared to the prior fiscal year.
- Over the 2009–2025 period, AtriCure, Inc.’s operating income has grown by 39.1% (from -$15.51 million to -$9.45 million).
- The most recent figure is from AtriCure, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: